Status:
ACTIVE_NOT_RECRUITING
Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome
Lead Sponsor:
Asfendiyarov Kazakh National Medical University
Conditions:
Frail Elderly Syndrome
Eligibility:
All Genders
60+ years
Brief Summary
Assessing frailty syndrome in elderly patients in Almaty To study the features of the clinical course in the group of patients with a pre-frailty and in the group with frailty syndrome
Detailed Description
2 cohorts of patients: a group of patients with pre-frailty (300 patients) and a group of patients with frailty syndrome (300 patients). Comparative analysis of the indicators of two groups (demograp...
Eligibility Criteria
Inclusion
- Patients over 60 years of age
- Signatories of the informed consent to participate in the study
Exclusion
- Not agreeing to participate in scientific research
- Elderly people who do not understand the purpose of the study
- Severe and decompensated diseases that do not allow the study.
- Concomitant oncological diseases
- Concomitant neurological and mental disorders that impede the study
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06496022
Start Date
March 1 2024
End Date
March 1 2025
Last Update
July 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kazakh National Medical University
Almaty, Tole Bi 94, Kazakhstan, 050012